Earlier this week, the American Cancer Society updated its colorectal cancer screening guidelines, reaffirming Abbott’s Cologuard and Cologuard Plus as preferred noninvasive options for average-risk ...

Abbott said that Ultreon 3.0 is the first optical coherence tomography (OCT) system in both the US and Europe that combines ...

ABT's Diagnostics unit witnesses mixed Q1 results as Core Lab growth offsets China weakness and softer respiratory testing demand.

Illinois-based Abbott Laboratories (ABT) is a diversified healthcare company that develops and manufactures medical devices, diagnostics, nutritional products, and branded generic medicines. Valued at ...

In 2013, Abbott Labs shifted to focus on generics, medical devices, diagnostics, and nutrition. Since then, it has grown its business and become much more robust and diverse. While it has benefited ...

Abbott’s ABT first-quarter results demonstrated underlying strength even as the diagnostics segment saw significant declines on diminishing demand for COVID-19 tests. As these dynamics were already ...

Carillon Tower Advisers, an investment management company, released its first-quarter 2026 investor letter for the “Carillon Eagle Growth & Income Fund”. A copy of the letter is available to download ...

Abbott Laboratories settled a proposed Illinois Genetic Information Privacy Act class suit brought by a worker who alleged ...